Summary & Overview
HCPCS A2040: Microlyte Painguard, Topical Wound Pain-Management Dressing
HCPCS Level II code A2040 represents the Microlyte painguard product billed per square centimeter, a topical wound pain-management dressing used to provide localized analgesia and protect skin and wound surfaces. Nationally, device and dressing codes like A2040 matter because they affect coverage determinations, provider billing practices, and patient access to wound care and topical pain-management options.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for use of the product, typical sites of service where it is applied, and the kinds of claims lines that include per-square-centimeter billing. The publication summarizes expected billing use, highlights national payer implications for coverage and coding clarity, and points to areas where policy updates or local payer edits may affect reimbursement and claim adjudication.
This summary equips billing managers, clinicians, and policy analysts with the core information needed to identify A2040 on a claim, understand its clinical role in wound and pain management, and anticipate payer interactions at a national level. Data not available in the input is noted where relevant.
Billing Code Overview
HCPCS Level II code A2040 refers to Microlyte painguard, billed per square centimeter. This item is classified as a topical wound pain-management dressing or topical barrier applied to the skin surface to provide localized pain relief and protect wounds.
-
Service type: Durable medical supply / topical wound pain-management dressing
-
Typical site of service: Hospital outpatient departments, ambulatory surgical centers, wound care clinics, and other outpatient care settings where topical dressings are applied
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a chronic or acute wound (pressure ulcer, venous stasis ulcer, diabetic foot ulcer, or postoperative wound) requiring topical wound care. The clinician selects A2040 Microlyte painguard, charged per square centimeter, to apply a topical pain-relieving dressing or gel to the wound bed during an outpatient wound clinic visit or home health nursing visit. The workflow includes wound assessment (size, depth, exudate), wound cleansing, measurement and documentation of wound surface area in square centimeters, application of the A2040 product to the wound surface, placement of an appropriate secondary dressing, and documentation of product type, quantity (area used), and clinical rationale. Typical sites of service are outpatient wound care clinics, physician offices, and home health visits where topical pain management at the wound site is provided as part of overall wound therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | Use when a distinct E/M service is provided on the same day as application of A2040 and is documented separately. |